1. Home
  2. Pharma & Healthcare
  3. Global Varicella Vaccine Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Varicella Vaccine Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 133 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Varicella Vaccine market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Varicella Vaccine market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Varicella Vaccine in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Injection
Freeze-Dried Powder

Market Snapshot, By Application
Kids Injection
Adults Injection

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Shanghai Institute
Merck
Keygen
GSK
Green Cross
Changsheng
Biken
BCHT

The study objectives of this report are:
To study and analyze the global Varicella Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Varicella Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Varicella Vaccine manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Varicella Vaccine market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Varicella Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Varicella Vaccine are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Varicella Vaccine Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Varicella Vaccine Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Varicella Vaccine

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Varicella Vaccine Sales Channel and Distributors Analysis
3.3.1 Varicella Vaccine Sales Channel
3.3.2 Varicella Vaccine Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Varicella Vaccine Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Varicella Vaccine Type Introduction
4.1.1 Injection
4.1.2 Freeze-Dried Powder
4.2 Global Varicella Vaccine Sales by Type 2016-2021
4.3 Global Varicella Vaccine Revenue by Type 2016-2021
4.4 Global Varicella Vaccine Price by Type 2016-2021

5 Market Segment: by Application
5.1 Varicella Vaccine Type Introduction
5.1.1 Kids Injection
5.1.2 Adults Injection
5.2 Global Varicella Vaccine Sales by Application 2016-2021
5.3 Global Varicella Vaccine Revenue by Application 2016-2021
5.4 Global Varicella Vaccine Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Varicella Vaccine Market by Region
6.1.1 Global Varicella Vaccine Sales by Regions
6.1.2 Global Varicella Vaccine Revenue by Regions
6.2 North America Varicella Vaccine Market 2016-2021
6.3 Europe Varicella Vaccine Market 2016-2021
6.4 Asia Pacific Varicella Vaccine Market 2016-2021
6.5 South America Varicella Vaccine Market 2016-2021
6.6 Middle East and Africa Varicella Vaccine Market 2016-2021

7 North America
7.1 North America Varicella Vaccine Market by Country 2016-2021
7.1.1 North America Varicella Vaccine Sales by Country
7.1.2 North America Varicella Vaccine Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Varicella Vaccine Market by Country 2016-2021
8.1.1 Europe Varicella Vaccine Sales by Country
8.1.2 Europe Varicella Vaccine Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Varicella Vaccine Market by Country 2016-2021
9.1.1 Asia Pacific Varicella Vaccine Sales by Country
9.1.2 Asia Pacific Varicella Vaccine Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Varicella Vaccine Market by Country 2016-2021
10.1.1 South America Varicella Vaccine Sales by Country
10.1.2 South America Varicella Vaccine Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Varicella Vaccine Market by Country 2016-2021
11.1.1 Middle East and Africa Varicella Vaccine Sales by Country
11.1.2 Middle East and Africa Varicella Vaccine Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Shanghai Institute
12.1.1 Shanghai Institute Company Information
12.1.2 Shanghai Institute Varicella Vaccine Product Portfolio, Specification and Application
12.1.3 Shanghai Institute Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Shanghai Institute Key Development
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Varicella Vaccine Product Portfolio, Specification and Application
12.2.3 Merck Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Merck Key Development
12.3 Keygen
12.3.1 Keygen Company Information
12.3.2 Keygen Varicella Vaccine Product Portfolio, Specification and Application
12.3.3 Keygen Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Keygen Key Development
12.4 GSK
12.4.1 GSK Company Information
12.4.2 GSK Varicella Vaccine Product Portfolio, Specification and Application
12.4.3 GSK Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 GSK Key Development
12.5 Green Cross
12.5.1 Green Cross Company Information
12.5.2 Green Cross Varicella Vaccine Product Portfolio, Specification and Application
12.5.3 Green Cross Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Green Cross Key Development
12.6 Changsheng
12.6.1 Changsheng Company Information
12.6.2 Changsheng Varicella Vaccine Product Portfolio, Specification and Application
12.6.3 Changsheng Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Changsheng Key Development
12.7 Biken
12.7.1 Biken Company Information
12.7.2 Biken Varicella Vaccine Product Portfolio, Specification and Application
12.7.3 Biken Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Changsheng Key Development
12.8.1 BCHT Company Information
12.8.2 BCHT Varicella Vaccine Product Portfolio, Specification and Application
12.8.3 BCHT Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 BCHT Key Development

13 Global Varicella Vaccine Market Forecast by Region by Type and by Application
13.1 Global Varicella Vaccine Sales, Revenue Forecast 2022-2027
13.2 Global Varicella Vaccine Forecast by Regions
13.2.1 Global Varicella Vaccine Sales Forecast by Region 2022-2027
13.2.2 Global Varicella Vaccine Revenue Forecast by Region 2022-2027
13.3 Global Varicella Vaccine Forecast by Type
13.3.1 Global Varicella Vaccine Sales Forecast by Type 2022-2027
13.3.2 Global Varicella Vaccine Revenue Forecast by Type 2022-2027
13.3.3 Global Varicella Vaccine Price Forecast by Type 2022-2027
13.4 Global Varicella Vaccine Forecast by Application
13.4.1 Global Varicella Vaccine Sales Forecast by Application 2022-2027
13.4.2 Global Varicella Vaccine Revenue Forecast by Application 2022-2027
13.4.3 Global Varicella Vaccine Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Varicella Vaccine Production Specifications
Table 2: Drivers in Varicella Vaccine Market
Table 3: Restraints Varicella Vaccine Market
Table 4: Opportunity in Varicella Vaccine Market
Table 5: Comparion of Alternative and Varicella Vaccine
Table 6: Varicella Vaccine Raw Materials Key Suppliers List
Table 7: Varicella Vaccine Distributors List
Table 8: Varicella Vaccine Major Buyers in Application One
Table 9: Varicella Vaccine Major Buyers in Application Two
Table 10: Varicella Vaccine Major Buyers in Application Three
Table 11: Global Varicella Vaccine Sales (K Units) by Type 2016-2021
Table 12: Global Varicella Vaccine Sales Market Share by Type 2016-2021
Table 13: Global Varicella Vaccine Revenue (Million USD) by Type 2016-2021
Table 14: Global Varicella Vaccine Revenue Market Share by Type 2016-2021
Table 15: Global Varicella Vaccine Price by Type 2016-2021
Table 16: Global Varicella Vaccine Sales (K Units) by Application 2016-2021
Table 17: Global Varicella Vaccine Sales Market Share by Application 2016-2021
Table 18: Global Varicella Vaccine Revenue (Million USD) by Application 2016-2021
Table 19: Global Varicella Vaccine Revenue Market Share by Application 2016-2021
Table 20: Global Varicella Vaccine Price by Application 2016-2021
Table 21: Global Varicella Vaccine Sales (K Units) by Region 2016-2021
Table 22: Global Varicella Vaccine Sales Market Share by Region 2016-2021
Table 23: Global Varicella Vaccine Revenue (Million USD) by Region 2016-2021
Table 24: Global Varicella Vaccine Revenue Market Share by Region 2016-2021
Table 25: North America Varicella Vaccine Sales (K Units) by Country 2016-2021
Table 26: North America Varicella Vaccine Sales Market Share by Country 2016-2021
Table 27: North America Varicella Vaccine Revenue (Million USD) by Country 2016-2021
Table 28: North America Varicella Vaccine Revenue Market Share by Country 2016-2021)
Table 29: Europe Varicella Vaccine Sales (K Units) by Country 2016-2021
Table 30: Europe Varicella Vaccine Sales Market Share by Country 2016-2021
Table 31: Europe Varicella Vaccine Revenue (Million USD) by Country 2016-2021
Table 32: Europe Varicella Vaccine Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Varicella Vaccine Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Varicella Vaccine Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Varicella Vaccine Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Varicella Vaccine Revenue Market Share by Country 2016-2021)
Table 37: South America Varicella Vaccine Sales (K Units) by Country 2016-2021
Table 38: South America Varicella Vaccine Sales Market Share by Country 2016-2021
Table 39: South America Varicella Vaccine Revenue (Million USD) by Country 2016-2021
Table 40: South America Varicella Vaccine Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Varicella Vaccine Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Varicella Vaccine Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Varicella Vaccine Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Varicella Vaccine Revenue Market Share by Country 2016-2021)
Table 45 Shanghai Institute Company Information
Table 46 Shanghai Institute Varicella Vaccine Product Portfolio, Specification and Application
Table 47 Shanghai Institute Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Merck Company Information
Table 49 Merck Varicella Vaccine Product Portfolio, Specification and Application
Table 50 Merck Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Keygen Company Information
Table 52 Keygen Varicella Vaccine Product Portfolio, Specification and Application
Table 53 Keygen Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 GSK Company Information
Table 55 GSK Varicella Vaccine Product Portfolio, Specification and Application
Table 56 GSK Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Green Cross Company Information
Table 58 Green Cross Varicella Vaccine Product Portfolio, Specification and Application
Table 59 Green Cross Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Changsheng Company Information
Table 61 Changsheng Varicella Vaccine Product Portfolio, Specification and Application
Table 62 Changsheng Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Biken Company Information
Table 64 Biken Varicella Vaccine Product Portfolio, Specification and Application
Table 65 Biken Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 BCHT Company Information
Table 67 BCHT Varicella Vaccine Product Portfolio, Specification and Application
Table 68 BCHT Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Varicella Vaccine Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Varicella Vaccine Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Varicella Vaccine Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Varicella Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Varicella Vaccine Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Varicella Vaccine Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Varicella Vaccine Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Varicella Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Varicella Vaccine Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Varicella Vaccine Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Varicella Vaccine Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Varicella Vaccine Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Varicella Vaccine Picture
Figure 2: Global Varicella Vaccine Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Varicella Vaccine Supply Chain Analysis
Figure 5: Varicella Vaccine Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Injection
Figure 7: Product Picture of Freeze-Dried Powder
Figure 8: Global Varicella Vaccine Sales Market Share by Type, 2020
Figure 9: Global Varicella Vaccine Revenue Market Share by Type, 2020
Figure 10: Varicella Vaccine in Kids Injection
Figure 11: Global Varicella Vaccine Market: Kids Injection 2016-2021
Figure 12: Varicella Vaccine in Adults Injection
Figure 13: Global Varicella Vaccine Market: Adults Injection 2016-2021
Figure 14: Global Varicella Vaccine Sales Market Share by Application, 2020
Figure 15: Global Varicella Vaccine Revenue Market Share by Application, 2020
Figure 16: Global Varicella Vaccine Sales Market Share by Region 2016-2021
Figure 17: Global Varicella Vaccine Revenue Market Share by Region 2016-2021
Figure 18: North America Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 19: North America Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 20: Europe Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 21: Europe Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 24: South America Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 25: South America Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 28: North America Varicella Vaccine Sales Market Share by Country, 2020
Figure 29: North America Varicella Vaccine Revenue Market Share by Country, 2020
Figure 30: United States Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 31: United States Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 32: Canada Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 33: Canada Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 35: Mexico Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 36: Europe Varicella Vaccine Sales Market Share by Country, 2020
Figure 37: Europe Varicella Vaccine Revenue Market Share by Country, 2020
Figure 38: Germany Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 39: Germany Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 40: France Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 41: France Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 42: UK Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 43: UK Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 44: Italy Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 45: Italy Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 46: Russia Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 46: Russia Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 47: Spain Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 48: Spain Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Varicella Vaccine Sales Market Share by Country, 2020
Figure 50: Asia Pacific Varicella Vaccine Revenue Market Share by Country, 2020
Figure 51: China Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 52: China Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 53: Japan Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 54: Japan Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 55: Korea Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 56: Korea Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 59: India Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 60: India Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 61: Australia Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 62: Australia Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 63: South America Varicella Vaccine Sales Market Share by Country, 2020
Figure 64: South America Varicella Vaccine Revenue Market Share by Country, 2020
Figure 65: Brazil Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 66: Brazil Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 68: Argentina Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 70: Colombia Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Varicella Vaccine Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Varicella Vaccine Revenue Market Share by Country, 2020
Figure 73: Turkey Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 74: Turkey Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Varicella Vaccine Sales (K Units) Status 2016-2021
Figure 78: South Africa Varicella Vaccine Revenue (Million USD) Status 2016-2021
Figure 79: Shanghai Institute Varicella Vaccine Revenue Market Share Globally (2019-2021)
Figure 80: Merck Varicella Vaccine Revenue Market Share Globally (2019-2021)
Figure 81: Keygen Varicella Vaccine Revenue Market Share Globally (2019-2021)
Figure 82: GSK Varicella Vaccine Revenue Market Share Globally (2019-2021)
Figure 83: Green Cross Varicella Vaccine Revenue Market Share Globally (2019-2021)
Figure 84: Changsheng Varicella Vaccine Revenue Market Share Globally (2019-2021)
Figure 85: Biken Varicella Vaccine Revenue Market Share Globally (2019-2021)
Figure 86: BCHT Varicella Vaccine Revenue Market Share Globally (2019-2021)
Figure 89: Global Varicella Vaccine Sales (K Units) Forecast (2022-2027)
Figure 90: Global Varicella Vaccine Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets